On December 8, 2023, the PTAB instituted three of Samsung Bioepis's pending IPRs against Alexion's Soliris® (eculizumab), IPR2023-00933, IPR2023-00998, and IPR2023-00999.
TAA Board Elects New Directors for 2024 bloodhorse.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bloodhorse.com Daily Mail and Mail on Sunday newspapers.
FRANKFORT – (TNS) Kentuckians must come together in unity during a time of angry division around the rest of the world, Democratic Gov. Andy Beshear said Tuesday as he started